Circular RNA SPI1 expression before and after induction therapy and its correlation with clinical features, treatment response, and survival of acute myeloid leukemia patients
Journal of Clinical Laboratory Analysis · 2023
DOI: 10.1002/jcla.24835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2023. Verfasst von Ting Xiong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, China. Hauptthemen laut MEDLINE: RNA, Circular, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Circular RNA spi‐1 proto‐oncogene (circ‐SPI1) regulates cell proliferation, apoptosis, and bone marrow differentiation in acute myeloid leukemia (AML). This study aimed to assess the relationship of circ‐SPI1 expression with the clinical features, induction therapy response, and survival of AML patients.
Methods
In total, 80 AML patients were included with bone marrow (BM) samples collected at baseline and after induction therapy. Additionally, 20 healthy donors (HDs) and 20 disease controls (DCs) were enrolled with BM samples collected after enrollment. BM circ‐SPI1 expression was detected by reverse‐transcription quantitative polymerase chain reaction assay.
Results
Circ‐SPI1 expression was highest in AML patients, moderate in DCs, and lowest in HDs (median (interquartile range): 3.01 [2.02–4.14] versus 1.71 [1.01–2.85] versus 0.98 [0.74–1.71]) ( p < 0.001). Moreover, lower circ‐SPI1 expression was related to its decreased located gene SPI1 expression ( p = 0.029), white blood cells (WBC) < 18.8 × 10 9 /L ( p = 0.010), trisomy 8 ( p = 0.025), and more favorable risk stratification ( p = 0.014) in AML patients. Additionally, circ‐SPI1 expression was reduced in AML patients after induction therapy ( p < 0.001), and its low expression after induction therapy was correlated with the achievement of complete remission ( p < 0.001). Furthermore, circ‐SPI1 decline ≥30% during therapy (versus
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Xianning Central Hospital, The First Affiliated Hospital of Hubei University of Science and Technology, Xianning, China.
- National Demonstration Center for Experimental General Medicine Education, Xianning Medical College, Hubei University of Science and Technology, Xianning, China.
ORCID-Profile: Qiaoqiao Song
Zitieren
APA
Xiong, T., Xia, L., & Song, Q. (2023). Circular RNA SPI1 expression before and after induction therapy and its correlation with clinical features, treatment response, and survival of acute myeloid leukemia patients. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.24835
Vancouver
Xiong T, Xia L, Song Q. Circular RNA SPI1 expression before and after induction therapy and its correlation with clinical features, treatment response, and survival of acute myeloid leukemia patients. Journal of Clinical Laboratory Analysis. 2023. doi:10.1002/jcla.24835
BibTeX
@article{Xiong2023,
author = {Xiong, Ting and Xia, Liqun and Song, Qiaoqiao},
title = {Circular RNA SPI1 expression before and after induction therapy and its correlation with clinical features, treatment response, and survival of acute myeloid leukemia patients},
journal = {Journal of Clinical Laboratory Analysis},
year = {2023},
doi = {10.1002/jcla.24835}
}
EUVIMED